Martin Duvall
Chairman at Oncopeptides, Inc.
Network origin in Martin Duvall first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
36
| Extinct | Pharmaceuticals: Major | 36 |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN.
31
| Extinct | Pharmaceuticals: Major | 31 |
| Subsidiary | Biotechnology | 30 | |
| Public Company | Pharmaceuticals: Major | 17 | |
| Extinct | Biotechnology | 14 | |
| Public Company | Pharmaceuticals: Major | 6 | |
Oncopeptides Incentive AB
4
| Subsidiary | 4 | |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Oncopeptides, Inc.
 Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Part of Oncopeptides AB, Oncopeptides, Inc. is a company committed to developing therapies for difficult-to-treat hematological diseases. The company is based in Waltham, MA. Oncopeptides strives to bring hope to patients through science and innovation, and is dedicated to bringing forward new and meaningful treatment options. The company is inspired by the perseverance of patients, caregivers, and healthcare providers in their fight against cancer. Oncopeptides' focus is on the development of therapies that can make a difference in the lives of those affected by hematological diseases.
2
| Subsidiary | Medical/Nursing Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Duvall via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | Founder Founder Director/Board Member Founder Investor Relations Contact Investor Relations Contact | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder Director/Board Member Chief Administrative Officer General Counsel Sales & Marketing | |
| Tufts University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact General Counsel Investor Relations Contact | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chairman Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Abraxis Health, Inc.
 Abraxis Health, Inc. BiotechnologyHealth Technology Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics. | Biotechnology | Chief Executive Officer Chief Operating Officer Comptroller/Controller/Auditor | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor General Counsel | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| University of Arizona | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member General Counsel Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| University of Stockholm | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Sales & Marketing Director/Board Member | |
Eisai Corp. of North America
 Eisai Corp. of North America Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Corp. of North America is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Miscellaneous Commercial Services | Founder Director/Board Member Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Rutgers State University of New Jersey | College/University | Graduate Degree Undergraduate Degree | |
American Association for the Advancement of Science
 American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Chairman Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Private Equity Investor | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| Purdue University | College/University | Undergraduate Degree Graduate Degree | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 44 |
| Canada | 3 |
| United Kingdom | 2 |
| Norway | 2 |
| Sweden | 2 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
Operational
| Director/Board Member | 384 |
| Corporate Officer/Principal | 267 |
| Independent Dir/Board Member | 118 |
| Undergraduate Degree | 74 |
| Chief Executive Officer | 74 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick Soon-Shiong | 52 |
| Franklin Berger | 41 |
| George Bickerstaff | 37 |
| Lonnie Moulder | 31 |
| David Parkinson | 31 |
| Paul Schimmel | 31 |
| Stig Anders Lindberg | 31 |
| Faheem Hasnain | 27 |
| Lori Kunkel | 27 |
| Jules Haimovitz | 27 |
| Alexander Denner | 25 |
| Mary Lynne Hedley | 25 |
| David Chen | 21 |
| Dawn Svoronos | 19 |
| Bruce Wendel | 19 |
- Stock Market
- Insiders
- Martin Duvall
- Company connections
